Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last SFr.150.20 CHF
Change Today +2.90 / 1.97%
Volume 19.0K
TECN On Other Exchanges
SIX Swiss Ex
As of 11:43 AM 11/27/15 All times are local (Market data is delayed by at least 15 minutes).

tecan group ag-reg (TECN) Snapshot

Previous Close
Day High
Day Low
52 Week High
11/27/15 - SFr.151.80
52 Week Low
01/29/15 - SFr.91.50
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for TECAN GROUP AG-REG (TECN)

Related News

No related news articles were found.

tecan group ag-reg (TECN) Related Businessweek News

No Related Businessweek News Found

tecan group ag-reg (TECN) Details

Tecan Group Ltd. provides laboratory instruments and automated workflow solutions for pharmaceutical and biotechnology companies, government research institutions and universities, diagnostic laboratories, and various applied markets. The company operates in two segments, Life Sciences Business and Partnering Business. It develops, produces, and distributes automation solutions, including instruments, software packages, numerous configurable modules, and special application knowhow, as well as consulting, services, and consumables. The company offers liquid handling platforms, which are used to pipette fluids with optimum precision and automate laborious and repetitive manual procedures; a range of bioanalytical instruments, such as microplate readers and washers that allows reactions to be monitored or analytes to be measured; and immunoassays for life science research and routine clinical diagnostics. It also develops and manufactures original equipment manufacturer instruments and components; and supplies laboratory instrument manufacturers with various components, such as precision pumps, valves, robotic arms, and development software under the Cavro brand. In addition, the company offers dedicated automation solutions comprising Dako Omnis, which is used in tissue-based cancer diagnostics; platform-based automation solutions; and pipette tips that acts as a component of a validated workflow solution, as well as detection instruments. Further, it provides ORTHO VISION analyzer, a diagnostics instrument that is used for blood typing; and determining other blood parameters. Tecan Group Ltd. distributes its products through its own market organization and distributors in approximately 50 countries worldwide. The company was founded in 1980 and is headquartered in Männedorf, Switzerland.

1,100 Employees
Last Reported Date: 03/27/15
Founded in 1980

tecan group ag-reg (TECN) Top Compensated Officers

Chief Executive Officer and Member of Managem...
Total Annual Compensation: SFr.855.0K
Chief Financial Officer, Executive Vice Presi...
Total Annual Compensation: SFr.459.0K
Compensation as of Fiscal Year 2014.

tecan group ag-reg (TECN) Key Developments

Phenomenex, Inc. Partners with Tecan Group Ltd. to Co-Market Automated Solid Phase Extraction of Sample Preparation Solutions

Phenomenex Inc. has partnered with Tecan Group Ltd. to co-market automated solid phase extraction (SPE) sample preparation solutions. The two companies will jointly market Phenomenex Strata (TM) and Strata-X SPE sorbents adapted to Tecan's Freedom EVO (R) series of robotics workstations. The solution is geared to customers in pharmaceutical research, clinical and food testing environments using mass spectrometry detection methods. As part of the global agreement, Tecan will provide the instruments and automation support, and Phenomenex will provide the extraction chemistries as well as application and method development through its PhenoLogixSM group. Solid phase extraction is a sample preparation technique by which compounds in mixtures are separated, prior to chromatographic analysis. Phenomenex Strata and Strata-X SPE sorbents remove unwanted contaminants including phospholipids.

Tecan Group AG Reports Earnings Results for the First Half Ended June 30, 2015; Provides Earnings Outlook for the Year 2015

Tecan Group AG reported earnings results for the first half ended June 30, 2015. For the period, the company’s sales were climbed by 18.9% in local currencies or 16.2% in Swiss francs to CHF 200.0 million against CHF 172.0 million for same period a year ago. Excluding the IBL International business, which was consolidated on August 1, 2014, the company grew by 13.0% in local currencies or 10.5% in Swiss francs. Operating profit before depreciation and amortization (earnings before interest, taxes, depreciation and amortization; EBITDA) rose by 21.4% to CHF 32.6 million against CHF 26.8 million for same period a year ago. The company’s net profit increased by 39.7% to CHF 26.0 million against CHF 18.6 million for same period a year ago. Earnings per share were increased by 37.5% to CHF 2.31 against CHF 1.68 for same period a year ago. Cash flow from operating activities more than doubled to CHF 35.1 million against CHF 16.2 million for same period a year ago. For fiscal 2015, the company continues to anticipate Group sales growth in the double-digit percentage range in local currencies, with an increase in the EBITDA margin of more than 100 basis points. The expectations regarding profitability are based on an average exchange rate forecast for full-year 2015 of one euro equaling CHF 1.05 and one US dollar equaling CHF 0.92, and exclude further acquisitions.

Tecan Group Ltd., H1 2015 Earnings Call, Aug 12, 2015

Tecan Group Ltd., H1 2015 Earnings Call, Aug 12, 2015


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TECN:SW SFr.150.20 CHF +2.90

TECN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for TECN.
View Industry Companies

Industry Analysis


Industry Average

Valuation TECN Industry Range
Price/Earnings 32.8x
Price/Sales 3.6x
Price/Book 4.0x
Price/Cash Flow 32.8x
TEV/Sales 3.2x

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact TECAN GROUP AG-REG, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at